February 6, 2026 11:07 AM
Today's Trading Session: Dr Reddys Laboratories Ltd Stock Falls
With a -0.31% decrease, Dr Reddys Laboratories Ltd's share price is now at 1241.00. The stock is currently trading at a PE of 18.8200, while the industry PE is 32.1534, prompting investors to assess its value proposition.
February 6, 2026 10:09 AM
Dr Reddys Laboratories Ltd Share Price Falls -0.31% in Today's Trading Session
Dr Reddys Laboratories Ltd witnessed a -0.31% drop in its share price and is currently trading at 1241.00. With the stock's PE at 18.8200 and the industry PE at 32.1534, investors are weighing their options.
February 6, 2026 9:09 AM
Today's Trading Session: Dr Reddys Laboratories Ltd Share Price Declines by -0.43%
Dr Reddys Laboratories Ltd experienced a -0.43% downturn in its share price, and it's currently trading at 1239.50. This situation is generating interest among value investors who are evaluating the stock's potential.
February 6, 2026 8:09 AM
Live Market Data: Dr Reddys Laboratories Ltd Share Price Falls -1.34% Today
The share price of Dr Reddys Laboratories Ltd plunged by -1.34%, leaving investors concerned. At this moment, the stock can be acquired at 1228.20, but investors are assessing whether this is a temporary dip or a long-term trend.
February 6, 2026 7:09 AM
Dr Reddys Laboratories Ltd Stock Slides Today
Dr Reddys Laboratories Ltd observed a -0.92% decrease in its share price, a situation that merits attention. As of now, it's actively trading at 1233.50. The stock has a PE ratio of 18.8200, an ROE of 16.0277 and a debt to equity ratio of 0.1625.
February 6, 2026 6:09 AM
Dr Reddys Laboratories Ltd Share Price in Red Today: Decline by -1.12%
The stock of Dr Reddys Laboratories Ltd suffered a -1.12% drop, and it's now trading at 1231.00 per share. Investors are assessing whether this decline represents a buying opportunity or a sign of ongoing challenges.
February 6, 2026 5:08 AM
Live Market Data: Dr Reddys Laboratories Ltd Share Price Drops -1.43% Today
Dr Reddys Laboratories Ltd's share price has fallen by -1.43%, presenting both challenges and opportunities for investors. As of now, it's trading at 1227.10, and market participants are assessing the implications. The stock has a PE ratio of 18.8200, an ROE of 16.0277 and a debt to equity ratio of 0.1625.